The new drug phenomenon
Simon D. Brandt, Leslie A. King, Michael Evans‐brown
Drug Testing and Analysis July 1, 2014 DOI: 10.1002/dta.1686 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Commentary Peer reviewed |
|---|---|
| Topics | Addiction |
| Keywords | Phenomenon Drug Pharmacology Engineering ethics |
| Citations | 164 |
| Key points | Argues that the drug market has changed markedly over the past decade through the rise of the "new drug phenomenon," in which entrepreneurs and increasingly criminal groups commodify a wide range of psychoactive substances not controlled under drug laws and sell them on an open market. The special issue presents multidisciplinary papers from the Third International Forum on New Drugs (Lisbon, June 2013) as a snapshot of these developments. |
Abstract
This special issue provides a multidisciplinary snapshot of recent developments of the broader, arguably phenomenal, changes to the drug market that have occurred in the past decade related to the rise of the new drug phenomenon. This change is largely a result of the growing commodification by entrepreneurs, and increasingly, by criminal groups, of a huge range of psychoactive substances not controlled under drug laws and fuelled by their sale on an open market. The issue includes papers that were presented at the Third International Forum on New Drugs, organized by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and held in Lisbon in June 2013.
Citations in the library
Cited by 34
- Baths Salts, Spice, and Related Designer Drugs: The Science Behind the Headlines Journal of Neuroscience November 12, 2014
- Return of the lysergamides. Part I: Analytical and behavioural characterization of 1‐propionyl‐d‐lysergic acid diethylamide (1P‐LSD) Drug Testing and Analysis October 12, 2015
- Return of the lysergamides. Part II: Analytical and behavioural characterization of N6-allyl-6-norlysergic acid diethylamide (AL-LAD) and (2’S,4’S)-lysergic acid 2,4-dimethylazetidide (LSZ) Drug Testing and Analysis June 6, 2016
- Return of the lysergamides. Part IV: Analytical and pharmacological characterization of lysergic acid morpholide (LSM‐775) Drug Testing and Analysis June 5, 2017
- First Reported Fatalities Associated with the 'Research Chemical' 2-Methoxydiphenidine Journal of Analytical Toxicology February 19, 2015
and 29 more in the library
Cites 12
- From PCP to MXE: a comprehensive review of the non-medical use of dissociative drugs. Drug Testing and Analysis 2014
- New psychoactive substances as adulterants of controlled drugs. A worrying phenomenon? Drug Testing and Analysis 2014
- An investigation of the stability of emerging new psychoactive substances Drug Testing and Analysis November 4, 2013
- New phenethylamines in Europe. Drug Testing and Analysis 2014
- Structure–activity relationships of serotonin 5‐HT2Aagonists Wiley Interdisciplinary Reviews Membrane Transport and Signalling February 28, 2012
and 7 more in the library